JPWO2022038281A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022038281A5 JPWO2022038281A5 JP2023512755A JP2023512755A JPWO2022038281A5 JP WO2022038281 A5 JPWO2022038281 A5 JP WO2022038281A5 JP 2023512755 A JP2023512755 A JP 2023512755A JP 2023512755 A JP2023512755 A JP 2023512755A JP WO2022038281 A5 JPWO2022038281 A5 JP WO2022038281A5
- Authority
- JP
- Japan
- Prior art keywords
- annexin
- pharmaceutical formulation
- seq
- liquid pharmaceutical
- formulation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20192142.6 | 2020-08-21 | ||
| EP20192142 | 2020-08-21 | ||
| PCT/EP2021/073186 WO2022038281A1 (en) | 2020-08-21 | 2021-08-20 | Annexin a1 n-terminal peptide formulations and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539476A JP2023539476A (ja) | 2023-09-14 |
| JP2023539476A5 JP2023539476A5 (https=) | 2024-08-27 |
| JPWO2022038281A5 true JPWO2022038281A5 (https=) | 2024-08-27 |
Family
ID=72193322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512755A Pending JP2023539476A (ja) | 2020-08-21 | 2021-08-20 | アネキシンａ１のｎ末端ペプチド製剤及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240041977A1 (https=) |
| EP (3) | EP4200320A1 (https=) |
| JP (1) | JP2023539476A (https=) |
| CN (1) | CN116323649A (https=) |
| AU (1) | AU2021327733A1 (https=) |
| CA (1) | CA3192030A1 (https=) |
| ES (1) | ES3031633T3 (https=) |
| HU (1) | HUE071875T2 (https=) |
| PL (1) | PL4200319T3 (https=) |
| WO (2) | WO2022038258A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3192030A1 (en) * | 2020-08-21 | 2022-02-24 | Resother Pharma A/S | Annexin a1 n-terminal peptide formulations and methods |
| WO2024003338A1 (en) * | 2022-06-30 | 2024-01-04 | Resother Pharma A/S | Annexin a1 liquid pharmaceutical composition |
| WO2024189056A1 (en) | 2023-03-13 | 2024-09-19 | Resother Pharma A/S | Annexin a1 administration regime |
| WO2024189054A1 (en) | 2023-03-13 | 2024-09-19 | Resother Pharma A/S | Annexin a1 delayed dosing |
| WO2025083393A1 (en) | 2023-10-16 | 2025-04-24 | Therakind Limited | Antimicrobial use of peptides derived from annexin a1 |
| WO2025083394A1 (en) | 2023-10-16 | 2025-04-24 | Therakind Limited | Antimicrobial use of annexin a1 protein |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9283260B2 (en) * | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
| AU2012271453B2 (en) * | 2011-06-15 | 2017-07-06 | Resother Pharma Aps | Anti-inflammatory pharmaceutical products |
| JP6117219B2 (ja) * | 2011-10-14 | 2017-04-19 | バクスアルタ ゲーエムベーハー | 陰イオン交換クロマトグラフィによるタンパク質の精製方法 |
| EP3838285A1 (en) | 2014-04-22 | 2021-06-23 | TXP Pharma GmbH | Peptide analogues with branched amino acid probe(s) |
| CN110302176A (zh) * | 2019-06-25 | 2019-10-08 | 中国人民解放军陆军军医大学 | 一种抗炎多肽纳米药物及制备方法 |
| CA3192030A1 (en) * | 2020-08-21 | 2022-02-24 | Resother Pharma A/S | Annexin a1 n-terminal peptide formulations and methods |
| WO2024003338A1 (en) * | 2022-06-30 | 2024-01-04 | Resother Pharma A/S | Annexin a1 liquid pharmaceutical composition |
-
2021
- 2021-08-20 CA CA3192030A patent/CA3192030A1/en active Pending
- 2021-08-20 ES ES21765917T patent/ES3031633T3/es active Active
- 2021-08-20 EP EP21766151.1A patent/EP4200320A1/en active Pending
- 2021-08-20 CN CN202180050871.2A patent/CN116323649A/zh active Pending
- 2021-08-20 EP EP25169758.7A patent/EP4595950A3/en active Pending
- 2021-08-20 JP JP2023512755A patent/JP2023539476A/ja active Pending
- 2021-08-20 WO PCT/EP2021/073125 patent/WO2022038258A1/en not_active Ceased
- 2021-08-20 WO PCT/EP2021/073186 patent/WO2022038281A1/en not_active Ceased
- 2021-08-20 AU AU2021327733A patent/AU2021327733A1/en active Pending
- 2021-08-20 HU HUE21765917A patent/HUE071875T2/hu unknown
- 2021-08-20 EP EP21765917.6A patent/EP4200319B1/en active Active
- 2021-08-20 US US18/041,729 patent/US20240041977A1/en active Pending
- 2021-08-20 PL PL21765917.6T patent/PL4200319T3/pl unknown
- 2021-08-20 US US18/041,727 patent/US20230295255A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6616931B1 (en) | Rotavirus vaccine formulations | |
| CA2272245A1 (en) | Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies | |
| RU2011127913A (ru) | Составы, содержащие антитела | |
| US6403098B1 (en) | Rotavirus vaccine formulations | |
| US8124109B2 (en) | Vault compositions for immunization against chlamydia genital infection | |
| EP1190257A1 (fr) | Detection precoce des flavivirus en utilisant la glycoproteine ns1 | |
| US10188724B2 (en) | Efficient mucosal vaccination mediated by the neonatal Fc receptor | |
| RU2484847C2 (ru) | Лиофилизированный препарат, содержащий гриппозную вакцину, и способ его получения | |
| US20240041977A1 (en) | Annexin a1 n-terminal peptide formulations and methods | |
| RU2014151424A (ru) | Термостабильные составы вакцины | |
| JPWO2022038281A5 (https=) | ||
| JPH01279843A (ja) | 凍結乾燥ａ型肝炎ワクチン | |
| CA2480226A1 (en) | Stable pharmaceutical composition containing factor viii | |
| US8647634B2 (en) | Recombinant avian infectious coryza vaccine and process for preparing same | |
| CN105745323B (zh) | 包含表达偏肺病毒(hMPV)抗原的重组活BCG的免疫原性制剂，其以无需佐剂地从冻干物制备的悬浮液形式存在并且适合于其制药用途 | |
| EP1353690A2 (fr) | Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin | |
| RU2024121592A (ru) | Лиофилизированная композиция, содержащая слитый белок, включающий α-галактозидазу А | |
| US20230391855A1 (en) | Chimeric anti-sars-cov2 nucleoprotein antibodies | |
| JPWO2021228052A5 (https=) | ||
| FR2794864A1 (fr) | Methode de detection precoce des flavivirus et ses applications | |
| AU2008202660B2 (en) | Rotavirus vaccine formulations | |
| JPWO2022256359A5 (https=) | ||
| CN120815063A (zh) | 一种重组腺病毒载体疫苗制剂及其制备方法 | |
| JP2023526335A (ja) | 免疫賦活活性を有する融合タンパク質 | |
| JPWO2021222355A5 (https=) |